BCL2L11 and ischemia: miR-19b-1 targets the pro-apoptotic Bcl-2 family gene (Bcl2l11/BIM), reducing its mRNA and protein levels, thereby reversing ischemia-induced HF by inhibiting myocardial cell apoptosis.